Thank you!
Your email has been successfully added to our mailing list.
CLOSE
Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
STOCK MARKET 101
About Us
Contact
Services
Institutions
Sign up
Log in
Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
STOCK MARKET 101
About Us
Contact
Services
Institutions
Log in
Sign up
×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks
Home
ACIU
News
ACIU –
ac immune sa
(US:NASDAQ)
DELAYED
<
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
——
ACIU
SPY
QQQ
SPX
News
Earning News
Analyst Actions
SEC Filings
Date
Time
Symbol
Headline
Impact
1/20
04:11 pm
aciu
AC Immune SA (
NASDAQ: ACIU
) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.
Low
REPORT
12/15
08:00 am
aciu
AC Immune Receives Competitive Target ALS Foundation Grant to Accelerate the Development of Proprietary Phosphorylated TDP-43 Immuno-assay
Low
REPORT
12/15
07:00 am
aciu
Target ALS Announces Second Round of 2020 Grant Recipients Focused on Discovering and Developing ALS Biomarkers
Medium
REPORT
12/8
01:40 pm
aciu
AC Immune SA (
NASDAQ: ACIU
) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
Low
REPORT
11/20
08:40 am
aciu
Immunotherapy Pioneer Prof. Carl H. June Joins AC Immune’s Board of Directors
Low
REPORT
11/18
07:00 am
aciu
Neurologist and Psychiatrist Prof. Johannes Rolf Streffer, MD Joins AC Immune SA as Chief Medical Officer
Low
REPORT
11/14
12:04 am
aciu
AC Immune SA (
NASDAQ: ACIU
) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.
Low
REPORT
11/13
07:00 am
aciu
AC Immune Reports Q3 2020 Financial Results and Provides Business Update
Medium
REPORT
11/12
07:00 am
aciu
AC Immune to Provide Strategy and Pipeline Update During Jefferies Virtual London Healthcare Conference
Low
REPORT
11/9
06:01 am
aciu
AC Immune and Wuxi Biologics boost development of TDP-43 antibodies [Seeking Alpha]
Medium
REPORT
11/9
04:00 am
aciu
AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immune’s Anti-TDP-43 Antibodies into Clinical Development
Medium
REPORT
10/30
06:01 am
aciu
AC Immune's Alzheimer's Setback, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
Low
REPORT
Live Event:
Click Here To Register For The Live Online Workshop
Latest Posts
Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day